monday.com Foundation to Resell 68,000 Shares

Ticker: MNDY · Form: 6-K · Filed: 2024-08-29T00:00:00.000Z

Sentiment: neutral

Topics: resale, shares, foundation

Related Tickers: MNDY

TL;DR

monday.com Foundation might sell 68k shares soon.

AI Summary

On August 29, 2024, monday.com Ltd. filed a prospectus supplement for the potential resale of up to 68,000 ordinary shares by the monday.com Foundation Ltd. This filing relates to shares that may be offered and sold by the Foundation.

Why It Matters

This filing indicates potential selling pressure on monday.com's stock from its associated foundation, which could impact share price if the shares are sold.

Risk Assessment

Risk Level: low — The filing is a standard prospectus supplement for resale of shares by a foundation, not indicative of company distress or significant new risk.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The purpose is to report a prospectus supplement filed on August 29, 2024, relating to the possible resale of up to 68,000 ordinary shares by the monday.com Foundation Ltd.

Who is filing the prospectus supplement?

monday.com Ltd. is filing the prospectus supplement.

Who is the potential seller of the ordinary shares?

The monday.com Foundation Ltd. is the potential seller of the ordinary shares.

How many ordinary shares are involved in the potential resale?

Up to 68,000 ordinary shares are involved in the potential resale.

Under which rule was the prospectus supplement filed?

The prospectus supplement was filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended.

Filing Stats: 397 words · 2 min read · ~1 pages · Grade level 10.7 · Accepted 2024-08-29 17:23:39

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MONDAY.COM LTD. By: /s/ Shiran Nawi Name: Shiran Nawi Title: Chief People and Legal Officer Date: August 29, 2024 EXHIBIT INDEX Exhibit Description 5.1 Opinion of Meitar Law Offices, Israeli Counsel to the Company 23.1 Consent of Meitar Law Offices, Israeli Counsel to the Company (included in Exhibit 5.1)

View on Read The Filing